MDB-68. DISCOVERING DRUG SENSITIVITIES IN MEDULLOBLASTOMA USING PATIENT- AND PDX-DERIVED TUMOROIDSChris Meulenbroeks, Marcel Kool, Anna Kołodziejczak et al.|Neuro-Oncology|2024Cited by 2
ETMR-18. ADVANCING ETMR RESEARCH: NOVEL<i>IN VITRO</i> AND<i>IN VIVO</i> PRECLINICAL MODELS FOR DEVELOPING MORE EFFECTIVE TREATMENTSMieke Roosen, Marcel Kool, Sonja Krausert et al.|Neuro-Oncology|2024Cited by 0
EPEN-17.<i>IN VITRO</i> MODELLING OF PEDIATRIC SUPRATENTORIAL EPENDYMOMAS USING CEREBRAL ORGANOIDSMieke Roosen, Marcel Kool, Julie Morscio et al.|Neuro-Oncology|2024Cited by 0
P10.27.B PRECLINICAL MODELLING AND DRUG SENSITIVITY DISCOVERY USING PATIENT- AND PDX-DERIVED TUMOROIDS OF HIGH RISK MEDULLOBLASTOMAChris Meulenbroeks, M Kool, Phylicia Stathi et al.|Neuro-Oncology|2025Cited by 0